In the follow-up study, we demonstrated that TWIST1 mediates decitabine (DAC) resistance of MDS/AML clone cells by binding to the gene promoter of DNA methyltransferase 3 (DNMT3) [6]. Here, TWIST1 is linked to acute myeloid leukemia.